Resources
View our poster on Assessing Comorbid Inflammatory Arthritis Conditions and Swollen to Tender Joint Count Ratios in a Real-World Systemic Lupus Erythematosus Cohort. Click to view more!
August 13, 2020- Aetion In a recent interview, Kathryn Starzyk, epidemiologist and Head of Real-World Evidence (RWE) at OM1, shared what makes OM1’s data unique, and how she and her team partner with biopharma and health systems to generate RWE that helps researchers better understand patient journeys in disease areas including rheumatology and immunology. Read on[…]
Thu. Sep 10, 2020 2:00 PM – 3:00 PM EDT Register Real-world data (RWD) is playing an increasing role in health care decisions, especially with autoimmune diseases where diagnosis can be difficult and there is no cure. Despite the promises of RWD to improve our understanding of the natural history of these diseases and to[…]
August 11, 2020 – HealthEconomics.com “Correctly identifying a patient with a rare disease can be like looking for a needle in a haystack”, according to Dr. Joseph Zabinski, Director, AI & Precision Medicine at OM1. But what if we could apply a magnet to the haystack, taking advantage of ‘hidden’ properties that – even without[…]
Published June 12, 2020, PharmaVoice.com Covid-19 taught the industry not to rely so heavily on the time and manual effort of clinicians and research staff to keep the research enterprise functioning. “Our focus in real-world data is through automated data networks — the first step in learning health systems — where research and practice are[…]
